SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001601830-24-000244
Filing Date
2024-12-17
Accepted
2024-12-17 17:05:45
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B7 rxrx-2024prospectussupplem.htm 424B7 579006
2 exfilingfees.htm   iXBRL EX-FILING FEES 33748
3 image_0.jpg GRAPHIC 13223
4 image_1.jpg GRAPHIC 3981
  Complete submission text file 0001601830-24-000244.txt   769410

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 5534
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-264845 | Film No.: 241556576
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)